Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease
Abhimanyu Krishna, Maria Biryukov, Christophe Trefois, et al.
BMC Genomics (2014) Vol. 15, Iss. 1, pp. 1154-1154
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 810
Characterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative Vulnerability
Julia Förster, Sandra Köglsberger, Christophe Trefois, et al.
SLAS DISCOVERY (2016) Vol. 21, Iss. 5, pp. 496-509
Open Access | Times Cited: 189
Advancement in the modelling and therapeutics of Parkinson’s disease
Sachchida Nand, Payal Singh
Journal of Chemical Neuroanatomy (2020) Vol. 104, pp. 101752-101752
Closed Access | Times Cited: 165
Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways
María‐Aránzazu Martínez, José-Luis Rodríguez, Bernardo López-Torres, et al.
Environment International (2019) Vol. 135, pp. 105414-105414
Open Access | Times Cited: 160
The cellular model for Alzheimer's disease research: PC12 cells
Danni Xie, Ting Deng, Zhenwei Zhai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 47
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
Harald Hampel, Sid E. O’Bryant, Juan I. Castrillo, et al.
The Journal of Prevention of Alzheimer s Disease (2016), pp. 1-17
Open Access | Times Cited: 103
Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
Shuang-Feng Xu, Yan-Hui Zhang, Shan Wang, et al.
Redox Biology (2018) Vol. 21, pp. 101090-101090
Open Access | Times Cited: 91
Control of cell state transitions
Oleksii S. Rukhlenko, Melinda Halász, Nora Rauch, et al.
Nature (2022) Vol. 609, Iss. 7929, pp. 975-985
Open Access | Times Cited: 58
Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
Jesús Alarcón-Gil, Ana Sierra‐Magro, José Á. Morales-García, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2297-2297
Open Access | Times Cited: 49
The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism
Guang Shi, G. Angus McQuibban
Cell Reports (2017) Vol. 18, Iss. 6, pp. 1458-1472
Open Access | Times Cited: 77
Using droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastoma
Marco Lodrini, Annika Sprüssel, Kathy Astrahantseff, et al.
Oncotarget (2017) Vol. 8, Iss. 49, pp. 85234-85251
Open Access | Times Cited: 70
Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis
Bo Chen, Jingjing Zhao, Rui Zhang, et al.
Nutritional Neuroscience (2020) Vol. 25, Iss. 5, pp. 1078-1099
Closed Access | Times Cited: 66
Characterization of three human cell line models for high‐throughput neuronal cytotoxicity screening
Zhi‐Bin Tong, Helena T. Högberg, David Kuo, et al.
Journal of Applied Toxicology (2016) Vol. 37, Iss. 2, pp. 167-180
Open Access | Times Cited: 62
Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
Sunil Kumar Dubey, Siva Ram Munnangi, Kowthavarapu Venkata Krishna, et al.
Cellular and Molecular Neurobiology (2019) Vol. 39, Iss. 2, pp. 181-209
Closed Access | Times Cited: 57
Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease
Albert Katchborian‐Neto, Wanderleya T. Santos, Karen de Jesus Nicácio, et al.
Journal of Ethnopharmacology (2020) Vol. 255, pp. 112743-112743
Open Access | Times Cited: 52
Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson’s disease
Xie Shi-shuai, Wanxiang Niu, Feng Xu, et al.
International Journal of Neuroscience (2020) Vol. 132, Iss. 7, pp. 673-688
Closed Access | Times Cited: 50
Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells
Stephanie Cristine Hepp Rehfeldt, Joana Silva, Celso Alves, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2914-2914
Open Access | Times Cited: 34
PM2.5 induces autophagy‐dependent ferroptosis by endoplasmic reticulum stress in SH‐SY5Y cells
Can Can Guo, Zhao Meng Xu, Yi Lyu, et al.
Journal of Applied Toxicology (2023) Vol. 43, Iss. 7, pp. 1013-1025
Closed Access | Times Cited: 17
Quantitative proteomic analysis identifies proteins and pathways related to neuronal development in differentiated SH-SY5Y neuroblastoma cells
Jimmy Rodriguez Murillo, Livia Goto‐Silva, Aniel Sánchez, et al.
EuPA Open Proteomics (2017) Vol. 16, pp. 1-11
Open Access | Times Cited: 56
Transcriptomic Profiling Discloses Molecular and Cellular Events Related to Neuronal Differentiation in SH-SY5Y Neuroblastoma Cells
Francesco Pezzini, Laura Bettinetti, Francesca Di Leva, et al.
Cellular and Molecular Neurobiology (2016) Vol. 37, Iss. 4, pp. 665-682
Closed Access | Times Cited: 48
Contributions of VPS35 Mutations to Parkinson’s Disease
Abir A. Rahman, Brad E. Morrison
Neuroscience (2019) Vol. 401, pp. 1-10
Open Access | Times Cited: 47
Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and Neuroprotection
Markéta Kubánková, Peter A. Summers, Ismael López‐Duarte, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 40, pp. 36307-36315
Open Access | Times Cited: 47
Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
Yu Zhang, Hui Guo, Xinyu Guo, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 20, pp. 3811-3811
Open Access | Times Cited: 47
RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs
Seung Hyuk Choi, Mathieu N. Flamand, Bei Liu, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111293-111293
Open Access | Times Cited: 23
Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders
Ruth Shah, Justyna Cholewa-Waclaw, Faith C.J. Davies, et al.
Wellcome Open Research (2016) Vol. 1, pp. 13-13
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top